Louis E, Resche-Rigon M, Laharie D, Satsangi J, et al. Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol 2023 Jan 11:S2468-1253(22)00385.
PMID: 36640794